Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pardes Biosciences, Inc. (FSII) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pardes Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1822711.
Total stock buying since 2021: $13,363,956.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 2,321,856 | $3,482,784 | 0 | $0 | 0 | $0 |
| 2022 | 695,920 | $606,172 | 0 | $0 | 0 | $0 |
| 2021 | 927,500 | $9,275,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-04 | 2,321,856 | $3,482,784 | 0 | $0 | 0 | $0 |
| 2022-12 | 695,920 | $606,172 | 0 | $0 | 0 | $0 |
| 2021-12 | 325,000 | $3,250,000 | 0 | $0 | 0 | $0 |
| 2021-02 | 602,500 | $6,025,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-05 | Tananbaum James B. | Buy | 1,547,904 | 1.50 | 2,321,856 |
| 2022-12-08 | Brusky Sean P. (Chief Commercial Officer) | Buy | 21,000 | 1.19 | 24,990 |
| 2022-12-02 | Wiggans Thomas G (Chief Executive Officer) | Buy | 12,500 | 1.07 | 13,375 |
| 2022-12-01 | Foresite Capital Fund V, L.p. | Buy | 637,420 | .85 | 541,807 |
| 2022-12-01 | Wiggans Thomas G (Chief Executive Officer) | Buy | 25,000 | 1.04 | 26,000 |
| 2021-12-22 | Foresite Capital Opportunity Management V, Llc | Buy | 325,000 | 10.00 | 3,250,000 |
| 2021-02-19 | Tananbaum James B. (President & CEO) | Buy | 602,500 | 10.00 | 6,025,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of FSII listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pardes Biosciences, Inc. (symbol FSII, CIK number 1822711) see the Securities and Exchange Commission (SEC) website.